Long-term follow-up of clozapine prescribing

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Psychopharmacology

• Publication date

  2018-04-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0269881118760666PMID 29692222
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Factors associated with changes in hospitalisation in patients prescribed clozapine

  2016cited by this paper
• Reasons for discontinuing clozapine: A cohort study of patients commencing treatment

  2016cited by this paper
• Reducing the rates of prescribing high-dose antipsychotics and polypharmacy on psychiatric inpatient and intensive care units: results of a 6-year quality improvement programme

  2015cited by this paper
• Practitioner attitudes to clozapine initiation

  2014cited by this paper
• Discontinuation of clozapine: a 15‐year naturalistic retrospective study of 320 patients

  2014cited by this paper
• Reason for clozapine cessation

  2012cited by this paper
• Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia.

  2012cited by this paper
• Predictors of Clozapine Response in Patients With Treatment-Refractory Schizophrenia: Results From a Danish Register Study

  2012cited by this paper
• Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation

  2012cited by this paper
• Predictors of clozapine discontinuation in patients with schizophrenia

  2011cited by this paper
• Schizophrenia and quality of life: how important are symptoms and functioning?

  2010cited by this paper
• Reasons for discontinuing clozapine: matched, case-control comparison with risperidone long-acting injection.

  2009cited by this paper
• Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.

  2008cited by this paper
• Outcome following clozapine discontinuation: a retrospective analysis.

  2007cited by this paper
• Risk of Clozapine-Associated Agranulocytosis and Mandatory White Blood Cell Monitoring

  2006cited by this paper
• Clozapine utilization and outcomes by race in a public mental health system: 1994-2000.

  2006cited by this paper
• Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.

  2006cited by this paper
• Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.

  2003cited by this paper
• The cost-effectiveness of clozapine: a controlled, population-based, mirror-image study

  2002cited by this paper
• Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.

  2002cited by this paper
• Schizophrenia costs and treatment cost‐effectiveness

  2000cited by this paper
• Medication continuation and compliance: a comparison of patients treated with clozapine and haloperidol.

  2000cited by this paper
• Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.

  1999cited by this paper
• Active monitoring of 12760 clozapine recipients in the UK and Ireland

  1999cited by this paper
• Long-term outcome with clozapine: comparison of patients continuing and discontinuing treatment.

  1998cited by this paper
• Long‐term outcome with clozapine: comparison of patients continuing and discontinuing treatment

  1998cited by this paper
• Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.

  1996cited by this paper
• Risk factors for clozapine discontinuation among 805 patients in the VA hospital system.

  1995cited by this paper
• Use of clozapine in Texas state mental health facilities.

  1993cited by this paper
• Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

  1988cited by this paper

• Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders

  2025cites this paper
• What is the current scope of research assessing patients’ and clinicians’ perspectives on clozapine treatment? A comprehensive scoping review

  2025cites this paper
• The paradox of clozapine in Black people with treatment-resistant schizophrenia

  2025cites this paper
• Lights and shadows of clozapine on the immune system in schizophrenia: a narrative literature review

  2025cites this paper
• Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug

  2024cites this paper
• High rates of myocarditis with clozapine in the Hunter region of Australia.

  2024cites this paper
• Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK.

  2023cites this paper
• Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study

  2023cites this paper
• Rates and Reasons for Clozapine Treatment Interruptions

  2023cites this paper
• Demographic and clinical characteristics of patients who recommence clozapine following therapy interruptions

  2021cites this paper
• Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals

  2020cites this paper
• Clozapine use – has practice changed?

  2020cites this paper
• Reasons for clozapine discontinuation in patients with treatment-resistant schizophrenia.

  2019cites this paper